Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design

被引：30

作者：

Venkatraman, S ^{[1
]}

Njoroge, FG ^{[1
]}

Girijavallabhan, VM ^{[1
]}

Madison, VS ^{[1
]}

Yao, NH ^{[1
]}

Prongay, AJ ^{[1
]}

Butkiewicz, N ^{[1
]}

Pichardo, J ^{[1
]}

机构：

[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 16期

关键词：

D O I：

10.1021/jm0489556

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Hepatitus C virus (HCV) NS3, when bound to NS-4A cofactor, facilitates development of mature virons by catalyzing cleavage of a polyprotein to form functional and structural proteins of HCV. The enzyme has a shallow binding pocket at the catalytic site, making development of inhibitors difficult. We have designed, preorganized, and depeptidized macrocyclic inhibitors from P-4 to P-2' and optimized binding to 0.1 mu M. The structure of an inhibitor bound to the enzyme was also solved.

引用

页码：5088 / 5091

页数：4

共 50 条

[31] Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease [J].

Chen, KX ;

Njoroge, FG ;

Prongay, A ;

Pichardo, J ;

Madison, V ;

Girilavallabhan, V .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) :4475-4478

[32] Hepatitis C virus NS3-4A protease inhibitors:: Countering viral subversion in vitro and showing promise in the clinic [J].

Thomson, John A. ;

Perni, Robert B. .

CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2006, 9 (05) :606-617

[33] Hepatitis C virus NS3-4A serine protease inhibitors:: SAR of P′2 moiety with improved potency [J].

Arasappan, A ;

Njoroge, FG ;

Chan, TY ;

Bennett, F ;

Bogen, SL ;

Chen, K ;

Gu, H ;

Hong, L ;

Jao, E ;

Liu, YT ;

Lovey, RG ;

Parekh, T ;

Pike, RE ;

Pinto, P ;

Santhanam, B ;

Venkatraman, S ;

Vaccaro, H ;

Wang, H ;

Yang, X ;

Zhu, Z ;

Mckittrick, B ;

Saksena, AK ;

Girijavallabhan, V ;

Pichardo, J ;

Butkiewicz, N ;

Ingram, R ;

Malcolm, B ;

Prongay, A ;

Yao, N ;

Marten, B ;

Madison, V ;

Kemp, S ;

Levy, O ;

Lim-Wilby, M ;

Tamura, S ;

Gangulya, AK .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) :4180-4184

[34] NS3-4A OF HEPATITIS-C VIRUS IS A CHYMOTRYPSIN-LIKE PROTEASE [J].

HAHM, B ;

HAN, DS ;

BACK, SH ;

SONG, OK ;

CHO, MJ ;

KIM, CJ ;

SHIMOTOHNO, K ;

JANG, SK .

JOURNAL OF VIROLOGY, 1995, 69 (04) :2534-2539

[35] Structure-based drug design and the evaluation of irreversible HCV-protease inhibitors [J].

Qiao, Lixin ;

Niu, Deqiang ;

Zhu, Zhendong ;

Labenski, Matt ;

Hagel, Margit ;

St Martin, Thia ;

Sheet, Michael ;

Bernard, Hugues ;

Nacht, Mariana ;

Westlin, Willian ;

Petter, Russell ;

Singh, Juswinder .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242

[36] High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants [J].

Kuegler, Jonas ;

Schmelz, Stefan ;

Gentzsch, Juliane ;

Haid, Sibylle ;

Pollmann, Erik ;

van den Heuvel, Joop ;

Franke, Raimo ;

Pietschmann, Thomas ;

Heinz, Dirk W. ;

Collins, John .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (46) :39224-39232

[37] Discovery of Hepatitis C Virus NS3-4A Protease Inhibitors with Improved Barrier to Resistance and Favorable Liver Distribution [J].

Moreau, Benoit ;

O'Meara, Jeff A. ;

Bordeleau, Josee ;

Garneau, Michel ;

Godbout, Cedrickx ;

Gorys, Vida ;

Leblanc, Melissa ;

Villemure, Elisia ;

White, Peter W. ;

Llinas-Brunet, Montse .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) :1770-1776

[38] Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design [J].

Chand, P ;

Babu, YS ;

Bantia, S ;

Chu, NM ;

Cole, LB ;

Kotian, PL ;

Laver, WG ;

Montgomery, JA ;

Pathak, VP ;

Petty, SL ;

Shrout, DP ;

Walsh, DA ;

Walsh, GW .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) :4030-4052

[39] β-Amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors [J].

Nurbo, Johanna ;

Peterson, Shane D. ;

Dahl, Goran ;

Danielson, U. Helena ;

Karlen, Anders ;

Sandstrom, Anja .

BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (10) :5590-5605

[40] Structure-based design of irreversible human rhinovirus 3C protease inhibitors. [J].

Dragovich, PS ;

Webber, SE ;

Babine, RE ;

Fuhrman, SA ;

Patick, AK ;

Matthews, DA ;

Reich, SH ;

Prins, TJ ;

Marakovits, JT ;

Littlefield, ES ;

Zhou, R ;

Tikhe, J ;

Ford, CE ;

Wallace, MB ;

Bleckman, TM ;

Meador, JW ;

Ferre, RA ;

Brown, EL ;

Binford, SL ;

DeLisle, DM ;

Worland, ST .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 :U863-U863

← 1 2 3 4 5 →